N-Methyl-2-phenoxyethanamine hydrochloride
CAS: 37421-04-8
Ref. 3D-FM132921
1g | Ausgelaufen | ||
2g | Ausgelaufen | ||
5g | Ausgelaufen | ||
250mg | Ausgelaufen | ||
500mg | Ausgelaufen |
Produktinformation
- methyl(2-phenoxyethyl)amine hydrochlorideethanamine
- N-methyl-2-phenoxy-
- hydrochloride
- Brn 2357146
- Ethanamine, N-methyl-2-phenoxy-
- Ethylamine, N-methyl-2-phenoxy-
- N-Methyl-N-(2-phenoxyethyl)amine
- N-Methylphenoxyethylamine
- N-methyl-2-phenoxyethanamine
- N-methyl-2-phenoxyethanaminium
- Mehr Synonyme anzeigen
- NSC 165619
- alpha-Phenoxy-beta-methylaminoethane
- N-Methyl-2-phenoxyethylamine
N-Methyl-2-phenoxyethanamine hydrochloride, also known as benfotiamine, is a thiamin derivative that stabilizes lysosomal membranes and prevents the accumulation of lipofuscin. It has been shown to be effective in the treatment of Gaucher disease, which is caused by mutations in β-glucocerebrosidase. Benfotiamine also has medicinal properties and can be used as an anti-dementia agent due to its ability to stabilize dopaminergic neurons. The drug is a quinazoline derivative that is synthesized from 2-phenoxyethanol and thiamine. It was designed for the treatment of Gaucher disease and was originally patented in Japan in 1966.br>br>